Physiologic characterization of endothelin A and B receptor activity in the ovine fetal pulmonary circulation

Journal of Clinical Investigation

Volumn 93, Issue 5, 1994, Pages 2141-2148

  Dunbar Ivy, D ^a,b   Kinsella, John P ^a   Abman, Steven H ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b CHILDREN S HOSPITAL   (United States)

Author keywords

BQ 123; CGS 27830; Nitric Oxide; pulmonary hypertension; sarafotoxin S6c

Indexed keywords

ENDOTHELIN; ENDOTHELIN RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; FETUS CIRCULATION; LUNG CIRCULATION; LUNG HEMODYNAMICS; LUNG VASCULAR RESISTANCE; NONHUMAN; PRIORITY JOURNAL; PULMONARY HYPERTENSION; REGULATORY MECHANISM; SHEEP;

EID: 23444436906     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/jci117210     Document Type: Article

References (56)

1. Heyman, M. A., R. K. Creasy, and A. M. Rudolph. 1973. Quantitation of blood flow patterns in the foetal lamb in utero. In Proceedings of the Sir Joseph Barcroft Symposium: Foetal and Neonatal physiology. Cambridge Univ. Press, Cambridge, UK. 129-135.
2. Cassin, S., G. S. Dawes, J. C. Mott, B. B. Ross, and L. B. Strang. 1964. The vascular resistance of the fetal and newly-ventilated lung of the lamb. J. Physiol. (Lond). 171:61-79.
3. Cassin, S., G. S. Dawes, and B. B. Ross. 1964. Pulmonary blood flow and vascular resistance in immature fetal lambs. J. Physiol. (Lond). 171:80-89.
4. Dawes, G. S., J. C. Mott, J. G. Widdicombe, and D. G. Wyatt. 1953. Changes of the lungs of the newborn lamb. J. Physiol. (Lond). 121:141-162.
5. Enhorning, G., F. H. Adams, and A. Norman. 1966. Effects of lung expansion on the fetal lamb circulation. Acta. Paediatr. Scand. 55:441-451.
6. Morin, F. C., E. A. Egan, W. Ferguson, and C. E. G. Lundgren. 1988. Development of pulmonary vascular response to oxygen. Am. J. Physiol. 254 (Heart Circ. Physiol. 23): H542-H546.
7. Walker, A. M., B. C. Ritchie, T. M. Adamson, and J. E. Maloney. 1988. Effect of changing lung volume on the pulmonary circulation of fetal lambs. J. Appl. Physiol. 64:61-67.
8. Soifer, S. J., R. D. Loitz, C. Roman, and M. A. Heymann. 1985. Leukotriene end organ antagonists increase pulmonary blood flow in fetal lambs. Am. J. Physiol. 249 (Heart Circ. Physiol. 18): H570-H576.
9. Yanagisawa, M., H. Kurihara, S. Kimura, Y. Tomobe, M. Kobayashi, Y. Mitsui, Y. Yazaki, K. Goto, and T. Masaki. 1988. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature (Lond.). 332:411-415.
10. MacCumber, M. W., C. A. Ross, B. M. Glaser, and S. H. Snyder. 1989. Endothelin: visualization of mRNAs by in situ hybridization provides evidence for local action. Proc. Natl. Acad. Sci. USA 86:7285-7289.
11. Nakamura, T., K. Kasai, S. Konuma, T. Emoto, N. Banba, M. Ishikawa, and S. Shimoda. 1990. Immunoreactive endothelin concentrations in maternal and fetal blood. Life Sci. 46:1045-1050.
12. Chatfield, B. A., I. F. McMurtry, S. L. Hall, and S. H. Abman. 1991. Hemodynamic effects of endothelin-1 in the ovine fetal pulmonary circulation. Am. J. Physiol. 261 (Regulatory Integrative Comp. Physiol. 30): R182-R187.
13. Cassin, S., T. Kristova, T. Davis, P. P. Kadowitz, and G. Gause. 1991. Tone-dependent responses to endothelin in the isolated perfused fetal sheep pulmonary circulation in situ. J. Appl. Physiol. 70:1228-1234.
14. Jones, O. W., and S. H. Abman. 1992. Hemodynamic Effects of Proendothelin-1 and Phosphoramidon in the Late Gestation Ovine Fetus. Am. J. Physiol. In Press.
15. Miller, R. C., J. T. Pelton, and J. P. Huggins. 1993. Endothelins-from receptors to medicine. TIPS (Trends Pharmacol. Sci.). 14:54-60.
16. Arai, H., S. Hori, I. Aramori, H. Ohkubo, and S. Nakanishi. 1990. Cloning and expression of a cDNA encoding an endothelin receptor. Nature (Lond.). 348:730-732.
17. Sakurai, T., M. Yanagisawa, Y. Takuwa, H. Miyazaki, S. Kimura, K. Goto, and T. Masaki. 1990. Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor. Nature (Lond.). 348:732-735.
18. Masaki, T., S. Kimura, M. Yanagisawa, and K. Goto. 1991. Molecular and cellular mechanisms of endothelin regulation. Implications for vascular function. Circulation. 84:1457-1468.
19. Hirata, Y., T. Emori, S. Eguchi, K. Kanno, T. Imai, K. Ohta, and F. Marumo. 1993. Endothelin receptor subtype B mediates synthesis of nitric oxide by cultured bovine endothelial cells. J. Clin. Invest. 91:1367-1373.
20. Shetty, S. S., T. Okada, R. L. Webb, D. DelGrande, and R. W. Lappe. 1993. Functionally distinct endothelin B receptors in vascular endothelium and smooth muscle. Biochem. Biophys. Res. Commun. 191:459-464.
21. Ihara, M., K. Noguchi, T. Saeki, T. Fukuroda, S. Kimura, T. Fukami, K. Ishikawa, M. Nishikibe, and M. Yano. 1992. Biological profiles of highly potent novel endothelin antagonists selective for the ET-A receptor. Life Sci. 50:247-255.
22. Williams, D. L., K. L. Jones, D. J. Pettibone, E. V. Lis, and B. V. Clineschmidt. 1991. Sarafotoxin S6c: an agonist which distinguishes between endothelin receptor subtypes. Biochem. Biophys. Res. Commun. 175:556-561.
23. Mugrage, B., J. Moliterni, L. Robinson, R. L. Webb, S. S. Shetty, K. E. Lipson, M. H. Chin, R. Neale, and C. Cioffi. 1993. CGS 27830, a potent nonpeptide endothelin receptor antagonist. Bioorg. & Medicin. Chem. Lett. 3:2099-2104.
24. Abman, S. H., F. J. Accurso, R. M. Ward, and R. B. Wilkening. 1986. Adaptation of fetal pulmonary blood flow to local infusion of tolazoline. Pediatr. Res. 20:1131-1135.
25. Wilkening, R. B., D. W. Boyle, and G. Meschia. 1988. Measurement of blood flow and oxygen consumption in the pelvic limb of fetal sheep. Proc. Soc. Exp. Biol. Med. 187:498-505.
26. Lewis, A. B., M. A. Heyman, and A. M. Rudolph. 1976. Gestational age changes in pulmonary vascular responses in fetal lambs in utero. Circ. Res. 39:536-541.
27. Lock, J. E., F. Hamilton, H. Luide, F. Coceani, and P. M. Olley. 1980. Direct pulmonary vascular responses in the conscious newborn lamb. J. Appl. Physiol. 48:188-196.
28. Assali, N. S., G. H. Johnson, C. R. Brinkman, and D. J. Huntsman. 1971. Effects of bradykinin on the fetal pulmonary circulation. Am. J. Physiol. 221:1375-1382.
29. Campbell, A. G., G. S. Dawes, A. P. Fishman, A. I. Hyman, and A. Perks. 1968. The release of bradykinin-like substance in fetal and newborn lambs. J. Physiol. (Lond.). 195:83-96.
30. Davidson, D. 1988. Pulmonary hemodynamics at birth: effects of acute cyclooxygenase inhibition in lambs. J. Appl. Physiol. 64:1676-1682.
31. Heymann, M. A., A. M. Rudolph, A. S. Nies, and K. L. Melmon. 1969. Bradykinin production associated with oxygenation of the fetal lamb. Circ. Res. 25:521-534.
32. Leffler, C. W., J. R. Hessler, and R. S. Green. 1984. The onset of breathing at birth stimulates pulmonary vascular prostacyclin synthesis. Pediarr. Res. 18:938-942.
33. Leffler, C. W., J. R. Hessler, and R. S. Green. 1984. Mechanisms of stimulation of prostacyclin synthesis at birth. Prostaglandins. 28:877-887.
34. Leffler, C. W., T. L. Tyler, and S. Cassin. 1978. Effect of indomethacin on pulmonary vascular response to ventilation of fetal goats. Am. J. Physiol. 235 (Heart Circ. Physiol. 4): H346-H351.
35. Morin, F. C., E. A. Egan, W. Ferguson, and C. E. G. Lundgren. 1988. Indomethacin does not diminish the pulmonary vascular response of the fetus to increased oxygen tension. Pediatr. Res. 24:696-700.
36. Tod, M. L., K. Yoshimura, and L. R. Rubin. 1991. Indomethacin prevents the ventilation induced decreases in pulmonary vascular resistance of the middle region in fetal lambs. Pediatr. Res. 29:449-454.
37. Abman, S. H., and K. R. Stenmark. 1992. Changes in lung eicosanoid content during normal and abnormal transition in perinatal lambs. Am. J. Physiol. 262 (Lung Cell. Mol. Physiol. 6): L214-L222.
38. Tod, M. L., and S. Cassin. 1992. Endothelin-1-induced pulmonary arterial dilation is reduced by N-nitro-L-arginine in fetal lambs. J. Appl. Physiol. 72:1730-1734.
39. Hasunuma, K., D. Rodman, R. F. O'brien, and I. McMurtry. 1990. Endothelin-1 causes pulmonary vasodilation in rats. Am. J. Physiol. 259 (Heart Circ. Physiol. 28): H48-H54.
40. D'Orleans, P., S. Telemaque, A. Claing, M. Ihara, and M. Yano. 1992. Human big-endothehn-1 and endothelin-1 release prostacyclin via the activation of ET-1 receptors in the rat perfused lung. Br. J. Pharm. 103:773-775.
41. Gardiner, S. M., A. M. Compton, T. Bennett, R. M. Palmer, and S. Monocada. 1989. N-monomethyl-L-arginine does not inhibit the hindquarters vasodilator action of endothelin-1 in conscious rats. Eur. J. Pharmacol. 171:237-240.
42. Minnes, R. K., L. A. MacMillian, J. A. Bellan, M. D. Kerstein, D. B. McNamara, and P. J. Kadowitz. 1989. Analysis of regional responses to endothelin in hindquarters vascular bed of cats. Am. J. Physiol. 256 (Heart Circ. Physiol. 25): H598-H602.
43. Sigiura, M., T. Inagami, G. M. Hare, and J. A. Jones. 1989. Endothelin action: inhibition by protein kinase C inhibitor and involvement of phosphoinositols. Biochem. Biophys. Res. Commun. 158:170-176.
44. Van Renterghem, C. P. Vigne, J. Barhanin, A. Schmid-Al-Liana, C. Frelin, and M. Lazdunski. 1988. Molecular mechanism of action of the vasoconstrictor peptide endothelin. Biochem. Biophys. Res. Commun. 157:977-985.
45. Haleen, S., J. S. Davis, D. M. LaDoucer, and J. A. Keiser. 1993. Why big endothelin-1 lacks a vasodilator response. J. Cardiovasc. Pharm. 22(Suppl. 8):S271-S273.
46. Ihara, M., K. Ishikawa, T. Fukuroda, T. Saeki, K. Funabashi, T. Fukami, H. Suda, and M. Yano. 1992. In vitro profile of a highly potent novel endothelin (ET) antagonist BQ-123 selective for the ET-A receptor. J. Cardiovasc. Pharm. 20(Suppl. 12):S11-S14.
47. Cioffi, C. L., R. F. Neale, R. H. Jackson, and M. A. Sills. 1992. Characterization of rat lung endothelin receptor subtypes which are coupled to phosphoinositide hydrolysis. J. Pharmacol. Exp. Ther. 262:611-618.
48. Sumner, M. S., T. R. Cannon, J. W. Mundin, D. G. White, and I. S. Watts. 1992. Endothelin ET-A and ET-B receptors mediate vascular smooth muscle contraction. Br. J. Pharmacol. 107:858-860.
49. Clozel, M., G. A. Gray, V. Brue, B. M. Loffler, and R. Osterwalder. 1992. The endothelin ET-B receptor mediates both vasodilation and vasoconstriction in vivo. Biochem. Biophys. Res. Commun. 186:867-873.
50. Moreland, S., D. M. McMullen, C. L. Delaney, V. G. Lee, and J. T. Hunt. 1992. Venous muscle contains vasoconstrictor ET-B-like receptors. Biochem. Biophys. Res. Commun. 184:100-106.
51. Cristol, J. P., T. Warner, C. Thiemermann, and J. R. Vane. 1993. Mediation via different receptors of the vasoconstrictor effects of endothelins and sarafotoxins in the systemic circulation and renal vasculature of the anaesthetized rat. Br. J. Pharmacol. 108:776-779.
52. Nakamichi, K., M. Ihara, M. Kobayashi, T. Saeki, K. Ishikawa, and M. Yano. 1992. Different distribution of endothelin receptor subtypes in pulmonary tissues revealed by the novel selective ligands BQ 123 and [Ala1,3,11,15]ET-1. Biochem. Biophys. Res. Commun. 182:144-150.
53. Kojima, T., I. Fukada, M. Takedatsu, Y. Hirata, and Y. Kobayashi. 1992. Circulating levels of ET and ANF during postnatal life. Acta Paediatr. 81:676-677.
54. Cacoub, P., R. Dorent, M. Genevieve, P. Nataf, A. Carayon, J. C. Piette, P. Godeau, C. Cabrol, and I. Gandjbakhch. 1993. Endothelin-1 in primary pulmonary hypertension and the Eisenmenger Syndrome. Am. J. Cardiol. 71:448-450.
55. Rosenberg, A. A., J. Kennaugh, S. L. Koppenhafer, M. Loomis, and S. H. Abman. 1993. Elevated immunoreactive endothelin-1 levels in infants with persistent pulmonary hypertension of the newborn. J. Pediatr. 123:109-114.
56. Allen, S. W., B. A. Chatfield, S. L. Koppenhafer, M. S. Schaffer, R. R. Wolfe, and S. H. Abman. Circulating immunoreactive endothelin-1 levels in children with pulmonary hypertension: association with acute hypoxic pulmonary vasoreactivity. 1993. Am. Rev. Respir. Dis. 148:519-522.